Literature DB >> 24335463

Is Chryseobacterium indologenes a shunt-lover bacterium? A case report and review of the literature.

Nida Ozcan1, Tuba Dal1, Alicem Tekin1, Selvi Kelekci1, Sukran Can1, Ozgur Ezin1, Idris Kandemir1, Kadri Gul1.   

Abstract

Chryseobacterium indologenes is a non-fermentative Gram-negative bacillus formerly belonging to the Flavobacterium genus. It is widely found in water and soil, also on wet surfaces of the hospital environment. It rarely causes infections and is usually associated with altered immune status or indwelling devices. We present a case of ventriculoperitoneal shunt infection caused by C. indologenes in a premature pediatric patient. A six-month-old male infant with congenital hydrocephalus and ventriculoperitoneal shunt was admitted with complaints of irritability, high fever and projectile vomiting. He was diagnosed as suffering from meningitis based on the clinical symptoms and laboratory findings of cerebrospinal fluid. The ventriculoperitoneal shunt was externalized and cerebrospinal fluid samples were sent for bacterial cultures. The isolated bacterium was identified as C. indologenes by conventional methods and the BD Phoenix™ 100 (Becton Dickinson, MD, USA) fully automated microbiology system. Antimicrobial susceptibility testing was performed by the microdilution method and Kirby-Bauer's disk diffusion method according to the Clinical and Laboratory Standards Institute guidelines. The isolate was found susceptible to ciprofloxacin, levofloxacin, cefoperazone and trimethoprim-sulfamethoxazole, while it was resistant to amikacin, aztreonam, cefepime, ceftazidime, gentamicin, imipenem and ticarcillin-clavulanic acid. The treatment was started with trimethoprim-sulfamethoxazole and cefoperazone-sulbactam The ventriculoperitoneal shunt was then removed. The patient was fully healed after two weeks and discharged. Central nervous system infection is a rare form of C. indologenes infections. The case presented herein may make a useful contribution to the existing literature.

Entities:  

Mesh:

Year:  2013        PMID: 24335463

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  7 in total

Review 1.  Chryseobacterium indologenes: an emerging infection in the USA.

Authors:  Ridhwi Mukerji; Radhika Kakarala; Susan Jane Smith; Halina G Kusz
Journal:  BMJ Case Rep       Date:  2016-04-06

2.  Pyrosequencing 16S rRNA genes of bacteria associated with wild tiger mosquito Aedes albopictus: a pilot study.

Authors:  Guillaume Minard; Florence-Hélène Tran; Audrey Dubost; Van Tran-Van; Patrick Mavingui; Claire Valiente Moro
Journal:  Front Cell Infect Microbiol       Date:  2014-05-14       Impact factor: 5.293

3.  Chryseobacterium indologenes Septicemia in an Infant.

Authors:  Turkan Aydin Teke; Fatma Nur Oz; Ozge Metin; Gulsum Iclal Bayhan; Zeynep Gökce Gayretli Aydin; Melek Oguz; Gonul Tanir
Journal:  Case Rep Infect Dis       Date:  2014-07-10

4.  Whole genome sequencing uncovers a novel IND-16 metallo-β-lactamase from an extensively drug-resistant Chryseobacterium indologenes strain J31.

Authors:  Shaoqiang Wu; Beiwen Zheng; Tingting Wang; Xiawei Jiang; Chunyan Feng; Ang Li; Huihui Dong
Journal:  Gut Pathog       Date:  2016-10-21       Impact factor: 4.181

5.  Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature.

Authors:  Serkan Atıcı; Zeynep Alp Ünkar; Kübra Erdem; Eda Kepenekli Kadayifci; Ayşe Karaaslan; Aslı Çınar Memişoğlu; Ahmet Soysal; Nurver Ülger Toprak; Güner Söyletir; Eren Özek; Mustafa Bakır
Journal:  Springerplus       Date:  2016-10-07

6.  Rare case of meningitis due to an emerging pathogen Chryseobacterium indologenes.

Authors:  Anuj Sud; Monica Chaudhary; C P Baveja; P N Pandey
Journal:  SAGE Open Med Case Rep       Date:  2020-06-26

7.  Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil.

Authors:  Marcelo Silva Folhas Damas; Roumayne Lopes Ferreira; Emeline Boni Campanini; Gabriela Guerrera Soares; Leslie Camelo Campos; Pedro Mendes Laprega; Andrea Soares da Costa; Caio César de Melo Freire; André Pitondo-Silva; Louise Teixeira Cerdeira; Anderson Ferreira da Cunha; Maria-Cristina da Silva Pranchevicius
Journal:  Front Med (Lausanne)       Date:  2022-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.